How Much You Need To Expect You'll Pay For A Good ABBV-744 combination therapy with chemotherapy
In Section C, individuals will receive ABBV-744 and oral navitoclax. In Section D, contributors will receive ABBV-744 and ruxolitinib. Members will acquire treatment until finally illness progression or maybe the individuals are unable to tolerate the study drugs.Probable new techniques for the analysis and treatment of AML. (A) The identification